This user has not filled out their profile yet.

Polldaddy
Check out Polldaddy, the most easy-to-use survey software around. Start creating beautiful online surveys today.

Create an Online Survey

The 2012 Financing Deal of the Year Is ... (Poll Closed)

  • bluebird bio
    43%

     
  • Ovascience
    2%

     
  • Intarcia
    2%

     
  • Foundation Medicine
    51%

     
  • Warp Drive Bio
    2%

     
  • Rusnano/Domain/CoDa
    1%

     
Posted 1 year ago.

1 Comment

  • Greg Baird - 1 year ago

    From an objective analysis of the numbers (scale & scope of accomplishment), there is no competition to INTARCIA's unprecedented $210M financing deal in this category. The massive Series C funding allows the company to do its own global Phase 3. Furthermore, there was an impressive amount of courage, determination & vision displayed when this small company turned down fistfuls of attractive term sheets (that most companies its size would have jumped at) in order not to forego the true prize of continued independence. Intarcia deserves this award for their sheer numbers, their sheer nerve, and their entrepreneurial accomplishment. They are building something important & valuable. If their Phase 3 is successful, Intarcia will be in an enviable position of strength to determine its future from there. As good as the competition is this year, Intarcia is the clear winner in this category.

Leave a Comment

0/4000 chars


Submit Comment